The stock of HealthEquity (NAS:HQY, 30-year Financials) is believed to be significantly undervalued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its

HealthEquity Inc. (HQY) is a gem. Not only can the company more than triple its highly profitable revenue stream at industry maturity, but it has a terrific business. Think of it as a combination of a mini Automatic Data Processing (ADP), a mini bank with no credit risk and a mini Visa (V). The stock is down 40% from its high, so the valuation has become reasonable. This company has been, and probably will be, growing its bottom line at over 20% for a few years.

Details

What is the biggest problem in the U.S.?

No doubt the cost of

According to GuruFocus Insider Data, these are the largest CEO buys during the past week.

G-III Apparel Group CEO bought 40,000 shares

G-III Apparel Group Ltd. (GIII) CEO and 10% Owner Morris Goldfarb bought 40,000 shares on July 11 at a price of $26.47. The price of the stock has increased by 3.06% since.

G-III Apparel Group makes a wide range of apparel, footwear, and accessories that it sells under its own brands, licensed brands, and private-label brands. Licenses are core to the company's business and come from well-known apparel brands, professional sports leagues, and over 100 colleges and universities.

The largest Insider Buys this week were for Fastenal Co. (FAST), HealthEquity Inc. (HQY), Hyster-Yale Materials Handling Inc. (HY) and NGM Biopharmaceuticals Inc. (NGM).

Fastenal Co. (FAST): Director Michael J. Ancius bought 1,104 shares

Director Michael J. Ancius bought 1,104 shares of FAST stock on July 18 at the average price of $30.13. The price of the stock has increased by 0.8% since.

Fastenal Co. is an American international industrial supply company that focuses on distributing industrial, safety, and construction supplies. The company has over 2,600 branches throughout the United States, Canada, Mexico, and Canada. The company has a market

Shares of AstroNova Inc. (ALOT) fell on Tuesday after the company reported first-quarter earnings per share of 12 cents on revenue of $31.49 million.

Further, the gross profit was $12.1 million, or 38.5% of revenue, up from 38% in the prior-year quarter. The increase was due to revenue growth and product mix.

Moreover, the company’s board of directors declared a regular quarterly cash dividend of 7 cents per share. The dividend represents a cash dividend of 28 cents per share on an annualized basis.

The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$1,000,000+” and duration to "April 2016."

According to the above filters, the following are recent buys and sells from company insiders in the past week.

On April 13, Clearlake Capital Partners IV, a 10% owner of Tangoe Inc. (TNGO), bought 1,202,000 shares in the company at the price of $7.25 per share. Since then, the price of the stock has risen by 8.8% to $7.89.

The company

According to GuruFocus Insider Data, these are the largest CEO sells during the past week: Gilead Sciences Inc., Boston Scientific Corp., Sonic Corp. and HealthEquity Inc.

Gilead Sciences Inc. (GILD): President and CEO John F. Milligan sold 112,000 shares

Milligan sold 112,000 shares on April 4 at an average price of $94.59. Gilead Sciences has a market cap of $131.34 billion; its shares were traded around $96.09 with a P/E ratio of 8.10 and P/S ratio of 4.51. The trailing 12-month dividend yield of Gilead Sciences stocks is 1.79%. The forward dividend yield is 1.79%. Gilead Sciences had an

Healthcare company HealthEquity (HQY) announced on Monday, May 11 the closing of a public offering of 4,427,500 shares of common stock priced at $25.90 per share.

In the secondary public offering, HealthEquity as a company sold $23.4 million worth of common stock while stock holders of the company sold a total of 3,455,000 shares of the stock.

On the same day as the public offering closure, four HealthEquity corporate insiders sold a large amount of shares worth $116.84 million all together.

These insiders include HealthEquity Founder, Director, and Vice Chairman Stephen Neeleman who sold 7.57% of his shares

It has been a rocky nine months for software stocks. After soaring 47.6% in 2013, the S&P Software and Services Select Industry Index1 was down 4.85% year-to-date as of September 30, 2014, and down 9.1% since its peak on March 5, 2014. In contrast, the S&P 500 Index was up 8% year-to-date as of September 30, outpacing software by roughly 10%.

U.S. equity markets experienced a sudden reversal in sentiment in late March and early April, sparked by concerns over interest rates and geopolitical unrest. Investors swiftly rotated away from high growth, smaller cap stocks into larger cap “value” stocks